Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
COMPONENT-LIMITED
Score updated Nov 20, 2026

SGMOQ — SANGAMO THERAPEUTICS, INC Dilution Risk Tracker

Track SGMOQ dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — higher scores indicate higher risk of share dilution.

Not financial advice. Do your own research before making any investment decisions.

Track SGMOQ — Get alerts when the score changes →

As of November 20, 2026, SANGAMO THERAPEUTICS, INC (SGMOQ) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. SANGAMO THERAPEUTICS, INC has a market capitalization of $45.57M, 414.29M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

Offering Ability
52
Cash Runway
65
Float Risk—
Warrant Exposure
40
Convertible Debt
40

Dilution Forecast

Forecast data not available for this ticker.

Market Data

Market Cap$45.57M
Shares Outstanding414.29M
FloatN/A
Cash$121.97M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding414.29MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$45.57MMarket data cache
Cash Runway9.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest8.35M
Days to Cover4.9
% of FloatN/A
FINRA data as of Oct 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-30
xbrl XBRL WARRANT 2025-11-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SGMOQ Dilution Snapshot

SANGAMO THERAPEUTICS, INC (SGMOQ) has a DilutionScore of 52/100, rated High dilution risk. Score date: November 20, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SGMOQ's DilutionScore is currently 52/100 (High risk), with 1 score change tracked over 89 days. The score improved from 38/100 (Medium risk).

Period Score Risk Level Duration
Oct 09 – Nov 20, 202652/100HIGH43 days
Aug 24 – Oct 08, 202638/100MEDIUM46 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track SGMOQ Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SGMOQ files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SGMOQ — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 7,727+ tracked stocks →

Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note